1. Home
  2. SRRK vs CVCO Comparison

SRRK vs CVCO Comparison

Compare SRRK & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$40.03

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

CVCO

Cavco Industries Inc. When Issued

HOLD

Current Price

$495.78

Market Cap

4.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
CVCO
Founded
2012
1965
Country
United States
United States
Employees
289
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.5B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
SRRK
CVCO
Price
$40.03
$495.78
Analyst Decision
Strong Buy
Hold
Analyst Count
11
1
Target Price
$55.10
$550.00
AVG Volume (30 Days)
1.1M
156.5K
Earning Date
05-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.74
EPS
N/A
18.55
Revenue
N/A
$2,142,713,000.00
Revenue This Year
N/A
$14.66
Revenue Next Year
$449.79
$7.70
P/E Ratio
N/A
$26.90
Revenue Growth
N/A
31.68
52 Week Low
$22.71
$393.53
52 Week High
$49.82
$713.01

Technical Indicators

Market Signals
Indicator
SRRK
CVCO
Relative Strength Index (RSI) 32.95 30.22
Support Level $29.32 $488.88
Resistance Level $42.54 $498.36
Average True Range (ATR) 2.24 21.46
MACD -0.62 -7.16
Stochastic Oscillator 1.77 5.18

Price Performance

Historical Comparison
SRRK
CVCO

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

Share on Social Networks: